CURE

Antibody-Drug Conjugates Such As Datroway and Trodelvy May Transform TNBC

Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...
Rolling Out

Breakthrough brings hope for triple-negative breast cancer

Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks estrogen, progesterone, and HER2 receptors ...
CURE

INT230-6 Combination Increases Response Rates in Triple-Negative Breast Cancer

Pathological complete response at surgery was higher with INT230-6 pre-treatment plus Keynote-522 (5/7; 71.4%) than with Keynote-522 alone (2/6; 33%), with one evaluation pending. Grade ≥3 adverse ...

Targeted treatments plus engineered immune cells may slow early spread of triple‑negative breast cancer, study reveals

A new study has revealed a promising new approach to curb the spread of triple-negative breast cancer, one of the most ...
University of California

New vulnerability identified in aggressive breast cancer

Researchers at University of California San Diego have identified a previously unrecognized treatment target for triple‑negative breast cancer (TNBC), the most aggressive subtype of breast cancer.
Medscape

Triple-negative Breast Cancer: Disease Entity or Title of Convenience?

Expression of α-basic-crystallin – Expressed in approximately 50% 33 Increased versus other intrinsic types * BLBC—variously defined (that is not restricted to tumors defined on gene-expression ...